These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 23679298)

  • 41. MTHFR polymorphisms and pancreatic cancer risk: lack of evidence from a meta-analysis.
    Li L; Wu SD; Wang JY; Shen XZ; Jiang W
    Asian Pac J Cancer Prev; 2012; 13(5):2249-52. PubMed ID: 22901202
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Methylenetetrahydrofolate reductase polymorphisms and susceptibility to esophageal cancer in Chinese populations: a meta-analysis.
    Yang YB; Shang YH; Tan YL; Kang XJ; Meng M; Zhao ZX
    Asian Pac J Cancer Prev; 2014; 15(3):1345-9. PubMed ID: 24606463
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association between MTHFR gene polymorphisms and the risk of autism spectrum disorders: a meta-analysis.
    Pu D; Shen Y; Wu J
    Autism Res; 2013 Oct; 6(5):384-92. PubMed ID: 23653228
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Systematic review and meta-analysis of the associations between maternal methylenetetrahydrofolate reductase polymorphisms and preterm delivery.
    Fang Q; Jiang Y; Liu Z; Zhang Z; Zhang T
    J Obstet Gynaecol Res; 2018 Apr; 44(4):663-672. PubMed ID: 29315997
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relationship between
    Öksüz E; Görgişen G; Oto G; Özdemir H; Aras A; Öksüz M; Gülaçar İM; Demirkol MH
    J Invest Surg; 2022 Jan; 35(1):83-91. PubMed ID: 33322951
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Methylenetetrahydrofolate reductase gene polymorphisms and skin cancer risk: a meta-analysis.
    Deng F; Gao Y; L V JH; Gao JM
    Cancer Genet; 2014; 207(7-8):299-305. PubMed ID: 25306137
    [TBL] [Abstract][Full Text] [Related]  

  • 47. C667T and A1298C polymorphisms of methylenetetrahydrofolate reductase gene and susceptibility to myocardial infarction: A systematic review and meta-analysis.
    Alizadeh S; Djafarian K; Moradi S; Shab-Bidar S
    Int J Cardiol; 2016 Aug; 217():99-108. PubMed ID: 27179899
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Methylenetetrahydrofolate reductase C677T polymorphism and cervical cancer risk: a meta-analysis.
    Guo LN
    Asian Pac J Cancer Prev; 2012; 13(5):2193-7. PubMed ID: 22901193
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association between IL-18 -607 C/A Polymorphism and the Risk of Prostate Cancer: A Meta-Analysis of Case-Control Studies.
    Yuanyuan G; Xue Y; Yachao L; Xiao F; Xu C
    Asian Pac J Cancer Prev; 2019 Jun; 20(6):1595-1602. PubMed ID: 31244277
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Associations of C677T polymorphism in methylenetetrahydrofolate reductase (MTHFR) gene with male infertility risk: A meta-analysis.
    Hong HH; Hu Y; Yu XQ; Zhou L; Lv MQ; Sun Y; Ren WJ; Zhou DX
    Eur J Obstet Gynecol Reprod Biol; 2017 May; 212():101-109. PubMed ID: 28363185
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Methylenetetrahydrofolate reductase genetic polymorphisms and esophageal squamous cell carcinoma susceptibility: a meta-analysis of case-control studies.
    Wen YY; Yang SJ; Zhang JX; Chen XY
    Asian Pac J Cancer Prev; 2013; 14(1):21-5. PubMed ID: 23534726
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MTHFR gene polymorphisms are not involved in pancreatic cancer risk: a meta-analysis.
    Tu YL; Wang SB; Tan XL
    Asian Pac J Cancer Prev; 2012; 13(9):4627-30. PubMed ID: 23167392
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of the methylenetetrahydrofolate reductase gene C677T polymorphism with the risk of male infertility: a meta-analysis.
    Zhu X; Liu Z; Zhang M; Gong R; Xu Y; Wang B
    Ren Fail; 2016; 38(2):185-93. PubMed ID: 26584688
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Case-control study on the association between four single nucleotide polymorphisms in folate metabolism way and the risk of congenital heart disease].
    Duan S; Li G; Qiu F; Zhao L; Zhao M; Wang L; Feng Z; Ma X
    Wei Sheng Yan Jiu; 2018 Jul; 47(4):536-542. PubMed ID: 30081977
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls.
    Qi X; Ma X; Yang X; Fan L; Zhang Y; Zhang F; Chen L; Zhou Y; Jiang J
    Breast Cancer Res Treat; 2010 Sep; 123(2):499-506. PubMed ID: 20135343
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MTHFR genetic polymorphism increases the risk of preterm delivery.
    Nan Y; Li H
    Int J Clin Exp Pathol; 2015; 8(6):7397-402. PubMed ID: 26261642
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic polymorphisms of methylenetetrahydrofolate reductase (MTHFR) gene Ala222Val and susceptibility to ovary cancer: a systematic review and meta-analysis.
    Pan X; Lu Y; Long Y; Yao D
    Tumour Biol; 2014 Mar; 35(3):2133-9. PubMed ID: 24146277
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MTHFR C677T gene polymorphism and head and neck cancer risk: a meta-analysis based on 23 publications.
    Niu YM; Deng MH; Chen W; Zeng XT; Luo J
    Dis Markers; 2015; 2015():681313. PubMed ID: 25802478
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MTHFR polymorphism and the risk of prostate cancer: a meta-analysis of case-control studies.
    Li XL; Xu JH
    Prostate Cancer Prostatic Dis; 2012 Sep; 15(3):244-9. PubMed ID: 22370724
    [TBL] [Abstract][Full Text] [Related]  

  • 60. No association of the MTHFR gene A1298C polymorphism with the risk of prostate cancer: A meta-analysis.
    Li D; Tian T; Guo C; Ren J; Yan L; Liu H; Xu Z
    Exp Ther Med; 2012 Mar; 3(3):493-498. PubMed ID: 22969917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.